跳至主要内容
临床试验/NCT05591274
NCT05591274终止不适用

Modulating Intraoperative Vasectomy Pain Using the SmileyScope Virtual Reality Interface

University of Miami1 个研究点 分布在 1 个国家目标入组 120 人开始时间: 2022年11月17日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
终止
入组人数
120
试验地点
1
主要终点
Pre-operative Anxiety

研究概览

简要总结

This study will evaluate whether or not wearing a virtual reality (VR) headset reduces pain and anxiety in patients undergoing vasectomy. The headset being used is the SmileyScope virtual reality interface, a device already undergoing study for approval by the U.S. Food and Drug Administration (FDA) to reduce pain and anxiety in patients aged 4 years and older undergoing needle blood draw or injection procedures. In this study, the SmileyScope virtual reality interface is considered an investigational device because it is not yet approved for use in adult males undergoing vasectomy.

详细描述

Vasectomy is a safe and effective procedure for permanent sterilization in males. More than 500,000 vasectomies are performed annually in the United States, and that number is expected to grow rapidly in the coming years. The procedure is safe and can be quickly performed in an outpatient setting. Complications of vasectomy are rare, and can include hematoma and infection, spermatic granulomas, and post-vasectomy pain syndrome in rare cases. Like all outpatient surgical procedures where the patient is not under general anesthesia, vasectomies involve intraoperative and immediate post-operative pain. While use of the no-scalpel technique and local anesthetic reduces intraoperative pain, expected operative pain is still one of the main reasons patients cite for not undergoing the procedure.

In our current study, the investigators aim to further modulate intraoperative pain using virtual reality goggles. In clinical trials, the SmileyScope device has been shown to reduce procedural pain in the pediatric population during venipuncture or intravenous cannulation. Results from those studies showed a statistically significant reduction in pain during intravenous procedures in the emergency department. This VR headset is undergoing study for approval by the U.S. Food and Drug Administration (FDA) to reduce pain and anxiety in patients aged 4 years and older undergoing needle blood draw or injection procedures. Currently, this device has been granted entrance to the FDA Safer Technologies Program. In this study, the SmileyScope virtual reality interface is considered an investigational device because it is not yet approved for use in adult males undergoing vasectomy. The aim of this study is to investigate whether this same virtual reality modality can be utilized to reduce pain during vasectomies.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
None

盲法说明

Patients will be randomized into one of three groups (interactive virtual reality, static virtual reality, and no virtual reality). Randomization sequence will be generated using a validated random number generator, and allocation concealment will be achieved via opaque envelope. Treatment (vasectomy with interactive VR, vasectomy with static VR, or vasectomy with no VR) will be known to patient and care provider only once the vasectomy procedure begins.

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Male
接受健康志愿者
是

入选标准

  • •Adult males 18 years or older who are undergoing elective vasectomy

排除标准

  • •Have a serious comorbid illness or condition that, in the opinion of the investigator, may compromise the safety or compliance of the subject or preclude successful completion of the study
  • •History of chronic pain disorder or chronic narcotic use
  • •Significant refractive error, unilateral blindness, epilepsy, or other conditions such as skin infections, cancer, etc. which could compromise the physical function of the headset.

研究组 & 干预措施

Interactive VR

Experimental

Patients will be wearing a virtual reality headset preloaded with an interactive VR scenario.

干预措施: SmileyScope Virtual Reality Headset (Device)

Static VR

Experimental

Patients will be wearing a virtual reality headset preloaded with a static, non-interactive VR scenario.

干预措施: SmileyScope Virtual Reality Headset (Device)

Control

No Intervention

Patients will not be wearing any virtual reality headset.

结局指标

主要结局

Pre-operative Anxiety

时间窗: up to 1 day

Anxiety will be measured via the State-Trait Anxiety Inventory (STAI) anxiety score \[Range 20-80; 20 = low anxiety, 80 = high anxiety\]

Post-operative Anxiety

时间窗: up to 1 day

Anxiety will be measured via the State-Trait Anxiety Inventory (STAI) anxiety score \[Range 20-80; 20 = low anxiety, 80 = high anxiety\]

Subjective Pre-operative Pain

时间窗: up to 1 day

Pain will be measured via numeric Likert pain scale \[0-10; 0 = no pain, 10 = highest pain\]

Subjective Post-operative Pain

时间窗: up to 1 day

Pain will be measured via numeric Likert pain scale; compared to baseline pain scale in pre-operative period \[0-10; 0 = no pain, 10 = highest pain\]

Post-procedure Satisfaction

时间窗: up to 1 day

Satisfaction will be measured via a questionnaire scored by Likert scale. Questionnaire will ask: "How satisfied were you with today's procedure, with 0 being not satisfied at all, and 10 being the most satisfied?" "How helpful was VR in managing your vasectomy today" (0 is least helpful, 10 is most helpful)"

次要结局

  • Physiological Post-operative Oxygen Saturation(up to 1 day)
  • Physiological Intra-operative Heart Rate(up to 1 day)
  • Physiological Intra-operative Skin Temperature(up to 1 day)
  • Physiological Intra-operative Oxygen Saturation(up to 1 day)
  • Physiological Post-operative Heart Rate(up to 1 day)
  • Physiological Post-operative Skin Temperature(up to 1 day)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验